Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mawson Infrastructure Group Inc. Director's Dealing 2018

Jan 16, 2018

35202_dirs_2018-01-16_6726fae2-d2f4-47a4-973d-698f922f5c64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-01-09

Reporting Person: Zarachia Yaakov (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-09 Common Stock, par value $0.001 per share P 9841 $0.105 Acquired 12330674 Direct
2018-01-10 Common Stock, par value $0.001 per share P 4000 $0.150 Acquired 12334674 Direct
2018-01-10 Common Stock, par value $0.001 per share P 9281 $0.142 Acquired 12343892 Direct